Loading...
Publication
Examining the role of market access in the pharmaceutical industry : a scoping review of european practices
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.49 MB | Adobe PDF |
Advisor(s)
Abstract(s)
No contexto evolutivo da indústria farmacêutica, o acesso ao mercado surge como um parâmetro crítico da prestação de cuidados de saúde, dos resultados para os doentes e de considerações económicas. Com o título "Examining the Role of Market Access in the Pharmaceutical Industry: A Scoping Review of European Practices", esta monografia pretende explorar a complexa rede de conceitos que moldam o panorama do acesso ao mercado farmacêutico no contexto europeu.
Objetivos: Esta monografia segue o protocolo de uma scoping review e fornece uma análise abrangente do Acesso ao Mercado no sector farmacêutico europeu, centrando-se na análise de três dimensões essenciais: Atividades de Acesso aos Mercado, Avaliação do Desempenho e Evolução das Estratégias de Acesso aos Mercado.
Metodologia: O estudo seguiu o protocolo de uma scoping review, que se focou em analisar a função de acesso ao mercado na indústria farmacêutica, destacando para isso uma variedade de atividades e estratégias e evolução da função.
Resultados: Foi destacado o papel crucial da colaboração interfuncional nas empresas farmacêuticas. Além disso, a criação estratégias de inteligência do consumidor, o envolvimento com stakeholders, a análise regulamentar, a transmissão de conhecimentos, a investigação em economia da saúde e o desenvolvimento de propostas de valor podem ser considerados parte das principais atividades chave da função. No que diz respeito à avaliação do desempenho, o nosso estudo sugeriu indicadores-chave de desempenho para medir o sucesso das iniciativas de acesso ao mercado. Estes abrangem o tempo de colocação no mercado, as taxas de inclusão em formulários, o número de parcerias estratégicas, a penetração no mercado e a prevalência de acordos de partilha de riscos. Além disso, a nossa investigação analisou a evolução de estratégias de acesso ao mercado, desde a gestão tradicional das vendas até às abordagens baseadas no valor.
Conclusões: Esta evolução exige uma abordagem estratégica e multifacetada do acesso ao mercado. Este estudo oferece informações pertinentes sobre as suas atividades, os critérios de avaliação do desempenho e a evolução das estratégias da função. Compreender a natureza multifacetada do acesso não é apenas uma questão de conformidade, mas um imperativo estratégico que guia a alocação de recursos em saúde.
In the evolving landscape of the pharmaceutical industry, the concept of access has emerged as a critical determinant of healthcare delivery, patient outcomes, and economic considerations. With the title "Examining the Role of Market Access in the Pharmaceutical Industry: A Scoping Review of European Practices," this monograph embarks on a journey to explore the complex web of dynamics shaping the European Pharmaceutical Market Access scenario. Objectives: This monograph provides a comprehensive examination of Market Access in the pharmaceutical sector, focusing on three essential dimensions: Market Access Activities, Performance Evaluation, and Evolution of Market Access Strategies. Methodology: The study encompasses a scoping review, analyzing an array of MA activities, strategies, and their impact on the industry's dynamics, summarized in three specific research questions. Results: Our findings underscore the central role of cross-functional collaboration within pharmaceutical companies. Futhermore, building customer intelligence, stakeholder engagement, policy analysis, knowledge dissemination, health economics outcomes research, value proposition development, can also be considered part of the function's key activities. When it comes to evaluating performance, in our study we suggested key performance indicators to measure the success of market access initiatives. These metrics encompass time-to-market, formulary inclusion rates, the number of strategic partnerships, market penetration, and the prevalence of risk-sharing agreements. Furthermore, our research delves into the evolution of market access strategies from traditional sales management to value-based approaches. Conclusions: The landscape of the pharmaceutical industry demands a strategic and multifaceted approach to Market Access. This study offers valuable insights into MA activities, performance evaluation criteria, and the evolution of strategies in the European pharmaceutical landscape. Understanding the multifaceted nature of MA is not just a matter of compliance but a strategic imperative, guiding the efficient allocation of resources and the commitment to improving patient outcomes.
In the evolving landscape of the pharmaceutical industry, the concept of access has emerged as a critical determinant of healthcare delivery, patient outcomes, and economic considerations. With the title "Examining the Role of Market Access in the Pharmaceutical Industry: A Scoping Review of European Practices," this monograph embarks on a journey to explore the complex web of dynamics shaping the European Pharmaceutical Market Access scenario. Objectives: This monograph provides a comprehensive examination of Market Access in the pharmaceutical sector, focusing on three essential dimensions: Market Access Activities, Performance Evaluation, and Evolution of Market Access Strategies. Methodology: The study encompasses a scoping review, analyzing an array of MA activities, strategies, and their impact on the industry's dynamics, summarized in three specific research questions. Results: Our findings underscore the central role of cross-functional collaboration within pharmaceutical companies. Futhermore, building customer intelligence, stakeholder engagement, policy analysis, knowledge dissemination, health economics outcomes research, value proposition development, can also be considered part of the function's key activities. When it comes to evaluating performance, in our study we suggested key performance indicators to measure the success of market access initiatives. These metrics encompass time-to-market, formulary inclusion rates, the number of strategic partnerships, market penetration, and the prevalence of risk-sharing agreements. Furthermore, our research delves into the evolution of market access strategies from traditional sales management to value-based approaches. Conclusions: The landscape of the pharmaceutical industry demands a strategic and multifaceted approach to Market Access. This study offers valuable insights into MA activities, performance evaluation criteria, and the evolution of strategies in the European pharmaceutical landscape. Understanding the multifaceted nature of MA is not just a matter of compliance but a strategic imperative, guiding the efficient allocation of resources and the commitment to improving patient outcomes.
Description
Trabalho Final de Mestrado Integrado, Ciências Farmacêuticas, 2023, Universidade de Lisboa, Faculdade de Farmácia.
Keywords
Market access Pharmaceutical industry Activities Performance Strategy Mestrado Integrado - 2023